期刊论文详细信息
Viruses
Genetic Modification of Hematopoietic Stem Cells as a Therapy for HIV/AIDS
Patrick Younan1  John Kowalski1 
[1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA; E-Mails:
关键词: HIV/AIDS;    Gene Therapy;    Stem Cell Transplantation;   
DOI  :  10.3390/v5122946
来源: mdpi
PDF
【 摘 要 】

The combination of genetic modification and hematopoietic stem cell (HSC) transplantation may provide the necessary means to develop an alternative treatment option to conventional antiretroviral therapy. As HSCs give rise to all hematopoietic cell types susceptible to HIV infection, modification of HSCs is an ideal strategy for the development of infection-resistant immune cell populations. Although promising results have been obtained in multiple animal models, additional evidence is needed to convincingly demonstrate the feasibility of this approach as a treatment of HIV-1 infected patients. Here, we review the potential of HSC transplantation and the recently identified limitations of this approach. Using the Berlin Patient as a model for a functional cure, we contrast the confines of autologous versus allogeneic transplantation. Finally, we suggest that although autologous, gene-modified HSC-transplantation may significantly reduce plasma viremia, reaching the lower detection limits currently obtainable through daily HAART will remain a challenging endeavor that will require innovative combinatorial therapies.

【 授权许可】

CC BY   
© 2013 by the authors; licensee MDPI, Basel, Switzerland.

【 预 览 】
附件列表
Files Size Format View
RO202003190031025ZK.pdf 530KB PDF download
  文献评价指标  
  下载次数:9次 浏览次数:22次